TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
GlaxoSmithKline AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
720,761
|
620,150
|
640,656 |
Financial expenses |
1,053
|
283
|
217 |
Earnings before taxes |
22,940
|
19,970
|
20,779 |
EBITDA |
23,000
|
21,626
|
22,801 |
Total assets |
230,774
|
236,449
|
273,265 |
Current assets |
225,997
|
235,604
|
270,449 |
Current liabilities |
167,684
|
172,831
|
200,423 |
Equity capital |
62,953
|
61,657
|
67,864 |
- share capital |
33,584
|
33,412
|
36,357 |
Employees (average) |
76
|
70
|
69 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
27.3%
|
26.1%
|
24.8% |
Turnover per employee |
9,484
|
8,859
|
9,285 |
Profit as a percentage of turnover |
3.2%
![]() |
3.2%
![]() |
3.2% |
Return on assets (ROA) |
10.4%
|
8.6%
|
7.7% |
Current ratio |
134.8%
|
136.3%
|
134.9% |
Return on equity (ROE) |
36.4%
|
32.4%
|
30.6% |
Change turnover |
97,418
|
31,388
|
-27,718 |
Change turnover % |
16%
|
5%
|
-4% |
Chg. No. of employees |
6
|
1
|
-4 |
Chg. No. of employees % |
9%
|
1%
|
-5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.